SCHEMBL24276802

SCHEMBL24276802

COc1ccc2c(c1)c1cc3cnccc3c(C)c1n2CCN(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 6/20 0.53
▸ HTR2A P28223 3/20 0.53
▸ HTR2C P28335 3/20 0.53
▸ TP53 P04637 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ STAT6 P42226 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ MAOA P21397 1/20 0.51
▸ MAOB P27338 1/20 0.51
▸ HASPIN Q8TF76 3/20 0.46
▸ DYRK2 Q92630 1/20 0.45
▸ ACHE P22303 2/20 0.42
▸ BCHE P06276 1/20 0.42
▸ HTR6 P50406 4/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30892421 1.00 DYRK1A (0.53) DYRK1AHTR2AHTR2CTP53CYP1A2
SCHEMBL24277799 0.87 TP53 (0.53) DYRK1AHTR2AHTR2CTP53CYP1A2
SCHEMBL24276869 0.87 MAOA (0.52) DYRK1ATP53CYP1A2CYP3A4CYP2D6
SCHEMBL29445169 0.87 MAOA (0.52) DYRK1ATP53CYP1A2CYP3A4CYP2D6
SCHEMBL24277158 0.84 TP53 (0.49) DYRK1AHTR2AHTR2CTP53CYP1A2
SCHEMBL30892424 0.84 CYP1A2 (0.49) TP53CYP1A2CYP3A4CYP2D6ALOX15
SCHEMBL24276801 0.84 CYP1A2 (0.49) TP53CYP1A2CYP3A4CYP2D6ALOX15
SCHEMBL29445115 0.84 TP53 (0.50) HTR2ATP53CYP1A2CYP3A4CYP2D6
SCHEMBL24277215 0.84 TP53 (0.50) HTR2ATP53CYP1A2CYP3A4CYP2D6
SCHEMBL24277206 0.83 CYP2D6 (0.54) DYRK1AHTR2AHTR2CCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS University of Florida Research Foundation, Incorporation (US) 2024-02-29 — — US disclosed
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS University of Florida Research Foundation, Incorporation (US) 2024-02-29 — — US disclosed
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS University of Florida Research Foundation, Incorporation (US) 2024-02-29 — — US disclosed
WO-2022055922-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS EXPANSION THERAPEUTICS, INC. (US) 2022-03-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS FUS, SNRPE, RRBP1 DYRK1A 4563/4885HTR2A 3031/4885HTR2C 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback